M2bio Sciences Inc

Chart & Performance

D1W1MN

P/E

—

P/S

—

EPS

Div Yield, %

—

Shrs. gr., 5y

—

Rev. gr., 5y

-3.41%

Revenues

Net income

CFO

Notes

No notes on this company yet

Write a private note on this company, for your eyes only

Add note

Profile

Wuhan General Group (China), Inc., through its subsidiaries, researches, develops, and commercializes a range of cannabidiol (CBD)-based products under the Dr. AnnaRx brand for pharmacies. It also focuses on exploring and developing other indications for psilocybin new therapies that will enable patients who suffer from mental illness. The company offers its products for medical applications, including cancer, mental disorders, chronic pain, and others. Wuhan General Group (China), Inc. is headquartered in Pointe-Claire, Canada.

URL

https://m2bio.co/

IPO date

Apr 01, 1998

Employees

700

Domiciled in

Incorporated in

Valuation

No data to show